These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10488707)

  • 1. Serum matrix metalloproteinase-3 (stromelysin-1) concentration in patients with chronic liver disease.
    Murawaki Y; Ikuta Y; Okamoto K; Koda M; Kawasaki H
    J Hepatol; 1999 Sep; 31(3):474-81. PubMed ID: 10488707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical usefulness of serum matrix metalloproteinase-2 concentration in patients with chronic viral liver disease.
    Murawaki Y; Yamada S; Ikuta Y; Kawasaki H
    J Hepatol; 1999 Jun; 30(6):1090-8. PubMed ID: 10406188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of serum matrix metalloproteinase (MMP)-9 to MMP-2 ratio as a biomarker in hepatocellular carcinoma.
    Yeh HC; Lin SM; Chen MF; Pan TL; Wang PW; Yeh CT
    Hepatogastroenterology; 2010; 57(97):98-102. PubMed ID: 20422881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinoma.
    Hayasaka A; Suzuki N; Fujimoto N; Iwama S; Fukuyama E; Kanda Y; Saisho H
    Hepatology; 1996 Nov; 24(5):1058-62. PubMed ID: 8903375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic potential of serum matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as non-invasive markers of hepatic fibrosis in patients with HCV related chronic liver disease.
    El-Gindy I; El Rahman AT; El-Alim MA; Zaki SS
    Egypt J Immunol; 2003; 10(1):27-35. PubMed ID: 15719620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in chronic hepatitis C patients.
    Badra G; Lotfy M; El-Refaie A; Obada M; Abdelmonem E; Kandeel S; Fathy A
    Acta Microbiol Immunol Hung; 2010 Mar; 57(1):29-42. PubMed ID: 20350877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum collagenase activity in patients with chronic liver disease.
    Murawaki Y; Koda M; Yamada S; Kawasaki H; Shima H; Burkhardt H
    J Hepatol; 1993 Jul; 18(3):328-34. PubMed ID: 8228126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis C. Relationship to interferon response.
    Kasahara A; Hayashi N; Mochizuki K; Oshita M; Katayama K; Kato M; Masuzawa M; Yoshihara H; Naito M; Miyamoto T; Inoue A; Asai A; Hijioka T; Fusamoto H; Kamada T
    J Hepatol; 1997 Mar; 26(3):574-83. PubMed ID: 9075665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum tissue inhibitor of metalloproteinases in patients with chronic liver disease and with hepatocellular carcinoma.
    Murawaki Y; Yamamoto H; Kawasaki H; Shima H
    Clin Chim Acta; 1993 Sep; 218(1):47-58. PubMed ID: 8299219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma matrix metalloproteinase-9 (gelatinase B) in patients with hepatocellular carcinoma.
    Murawaki Y; Ikuta Y; Okamoto K; Mimura K; Koda M; Kawasaki H
    Res Commun Mol Pathol Pharmacol; 2000; 108(5-6):351-7. PubMed ID: 11958288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum matrix metalloproteinase-1 in patients with chronic viral hepatitis.
    Murawaki Y; Ikuta Y; Idobe Y; Kawasaki H
    J Gastroenterol Hepatol; 1999 Feb; 14(2):138-45. PubMed ID: 10029294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between plasma levels of matrix metalloproteinase (MMP)-9 /MMP-2 ratio and alpha-fetoproteins in chronic hepatitis carrying hepatitis B virus.
    Chung TW; Kim JR; Suh JI; Lee YC; Chang YC; Chung TH; Kim CH
    J Gastroenterol Hepatol; 2004 May; 19(5):565-71. PubMed ID: 15086601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of serum matrix metalloproteinases MMP-2 and MMP-9 after human liver transplantation: increased serum MMP-9 level in acute rejection.
    Kuyvenhoven JP; Verspaget HW; Gao Q; Ringers J; Smit VT; Lamers CB; van Hoek B
    Transplantation; 2004 Jun; 77(11):1646-52. PubMed ID: 15201662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase-9 gene polymorphism in hepatocellular carcinoma patients with hepatitis B and C viruses.
    El Samanoudy A; Monir R; Badawy A; Ibrahim L; Farag K; El Baz S; Alenizi D; Alenezy A
    Genet Mol Res; 2014 Sep; 13(3):8025-34. PubMed ID: 25299117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the clinical significance of serum vascular endothelial growth factor and matrix metalloproteinase-9 in patients with hepatocellular carcinoma.
    Kamel L; Nessim I; Abd-el-Hady A; Ghali A; Ismail A
    J Egypt Soc Parasitol; 2005 Dec; 35(3):875-90. PubMed ID: 16333896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum lysyl oxidase activity in chronic liver disease in comparison with serum levels of prolyl hydroxylase and laminin.
    Murawaki Y; Kusakabe Y; Hirayama C
    Hepatology; 1991 Dec; 14(6):1167-73. PubMed ID: 1683640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical usefulness of plasma activities of gelatinase (matrix metalloproteinase-2 and 9) in chronic liver disease].
    Kwon OS; Lim DY; Kwon KA; Chung MG; Park DK; Kim SS; Kim YS; Kwon SY; Koo YS; Kim YK; Choi DJ; Kim JH; Hwang YJ; Byun KS; Lee CH
    Taehan Kan Hakhoe Chi; 2003 Sep; 9(3):222-30. PubMed ID: 14515040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum cathepsin activity in chronic liver diseases].
    Kucharz EJ; Kucharz M
    Z Gesamte Inn Med; 1986 Nov; 41(22):636-8. PubMed ID: 3031888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase is strongly activated in hepatocellular carcinoma but not in chronic hepatitis and cirrhosis.
    Park YM; Choi JY; Byun BH; Cho CH; Kim HS; Kim BS
    Exp Mol Med; 1998 Mar; 30(1):35-40. PubMed ID: 9873820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the clinical significance of serum matrix metalloproteinases MMP-2 and MMP-9 in patients with various chronic liver diseases and hepatocellular carcinoma.
    Kuyvenhoven JP; van Hoek B; Blom E; van Duijn W; Hanemaaijer R; Verheijen JH; Lamers CB; Verspaget HW
    Thromb Haemost; 2003 Apr; 89(4):718-25. PubMed ID: 12669127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.